These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37946746)

  • 21. Stereotactic body radiotherapy for adenoid cystic carcinoma metastatic to the lung: a case report.
    Kobayashi D; Abe T; Saitoh JI; Oike T; Sato H; Musha A; Mizukami T; Shimizu T; Nakano T; Ohno T
    J Med Case Rep; 2021 Apr; 15(1):156. PubMed ID: 33838695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential abscopal effect in extracranial and intracranial lesions after radiotherapy alone for vertebral bone metastasis of unknown primary: a case report.
    Ishikawa Y; Umezawa R; Yamamoto T; Takahashi N; Takeda K; Suzuki Y; Jingu K
    J Med Case Rep; 2022 Mar; 16(1):94. PubMed ID: 35248152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
    Bozorgmehr F; Hommertgen A; Krisam J; Lasitschka F; Kuon J; Maenz M; Huber PE; König L; Kieser M; Debus J; Thomas M; Rieken S
    BMC Cancer; 2019 Nov; 19(1):1074. PubMed ID: 31703637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid tumours showing oligoprogression to immune checkpoint inhibitors have the potential for abscopal effects.
    Ito M; Abe S; Adachi S; Oshima Y; Takeuchi A; Ohashi W; Iwata T; Ogawa T; Ota A; Kubota Y; Okuda T; Suzuki K
    Jpn J Radiol; 2024 Apr; 42(4):424-434. PubMed ID: 38093137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic body radiotherapy for lung metastases in a patient with giant cell tumor of bone: a case report and literature review.
    Feng L; Ye T; Zhang J; Yuan S; Chen Y; Chen J
    Ann Transl Med; 2022 Feb; 10(3):156. PubMed ID: 35284555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abscopal Resolution of a Hepatic Metastasis in a Patient with Metastatic Cholangiocarcinoma Following Radical Stereotactic Body Radiotherapy to a Synchronous Early Stage Non-small Cell Lung Cancer.
    Kim JO; Kim CA
    Cureus; 2019 Feb; 11(2):e4082. PubMed ID: 31019860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible abscopal effect after discontinuation of nivolumab in metastatic renal cell carcinoma.
    Nakajima N; Kano T; Oda K; Uchida T; Otaki T; Nagao K; Shimizu Y; Kawakami M; Kim H; Nitta M; Hasegawa M; Kawamura Y; Miyajima A
    IJU Case Rep; 2020 Sep; 3(5):215-218. PubMed ID: 32914080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer.
    Liu X; Chi A
    Front Oncol; 2023; 13():1211815. PubMed ID: 37746276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The abscopal effect: systematic review in patients with brain and spine metastases.
    Pangal DJ; Yarovinsky B; Cardinal T; Cote DJ; Ruzevick J; Attenello FJ; Chang EL; Ye J; Neman J; Chow F; Zada G
    Neurooncol Adv; 2022; 4(1):vdac132. PubMed ID: 36199973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abscopal Effects: Case Report and Emerging Opportunities.
    Lock M; Muinuddin A; Kocha WI; Dinniwell R; Rodrigues G; D'souza D
    Cureus; 2015 Oct; 7(10):e344. PubMed ID: 26623199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.
    Leidner R; Crittenden M; Young K; Xiao H; Wu Y; Couey MA; Patel AA; Cheng AC; Watters AL; Bifulco C; Morris G; Rushforth L; Nemeth S; Urba WJ; Gough M; Bell RB
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abscopal Effect after Radiosurgery for Solitary Brain Metastasis from Non-small Cell Lung Cancer.
    Hamilton AJ; Seid J; Verdecchia K; Chuba P
    Cureus; 2018 Dec; 10(12):e3777. PubMed ID: 30854265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects.
    Tubin S; Popper HH; Brcic L
    Radiat Oncol; 2019 Jan; 14(1):21. PubMed ID: 30696472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combing stereotactic body radiotherapy with checkpoint inhibitors after oligoprogression in advanced non-small cell lung cancer.
    Wang Z; Wei L; Li J; Zhou H; Li S; Chen D; Yu Y; Zhao L; Zhu X; Song Y
    Transl Lung Cancer Res; 2021 Dec; 10(12):4368-4379. PubMed ID: 35070747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nivolumab and stereotactic radiation therapy for the treatment of patients with Stage IV non-small-cell lung cancer.
    Miyamoto S; Nomura R; Sato K; Awano N; Kuse N; Inomata M; Izumo T; Terada Y; Furuhata Y; Bae Y; Kunitoh H
    Jpn J Clin Oncol; 2019 Feb; 49(2):160-164. PubMed ID: 30452687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer.
    Franzese C; Badalamenti M; Teriaca A; De Virgilio A; Mercante G; Cavina R; Ferrari D; Santoro A; Spriano G; Scorsetti M
    J Cancer Res Clin Oncol; 2021 May; 147(5):1307-1313. PubMed ID: 33471186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A long-term survival case of bladder cancer with distant metastases: abscopal effect of brain metastases after stereotactic radiotherapy with immune checkpoint blockade therapy to lung metastases.
    Kono S; Hashimoto Y; Shirai Y; Kunihiro Y; Ohmatsu K; Kawanishi M; Kuribayashi S; Karasawa K
    Int Cancer Conf J; 2023 Jul; 12(3):205-209. PubMed ID: 37251008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiation therapy for oligoprogression of metastatic disease from gastrointestinal cancers: A novel approach to extend chemotherapy efficacy.
    Wray J; Hawamdeh RF; Hasija N; Dagan R; Yeung AR; Lightsey JL; Okunieff P; Daily KC; George TJ; Zlotecki RA; Trevino J; Dang LH
    Oncol Lett; 2017 Mar; 13(3):1087-1094. PubMed ID: 28454218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A patient with metastatic non-small cell lung cancer who received pembrolizumab monotherapy after stereotactic body radiotherapy had progression-free survival of nearly 5 years: a case report.
    Ni J; Yang L; Zhu H; Chu M; Zhang C; Zhao W; Yang M; Xu X; Zheng E; Jiang X; Li R; Zhao G
    Ann Palliat Med; 2021 Apr; 10(4):4999-5009. PubMed ID: 33966436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.